<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2709-7927</journal-id>
<journal-title><![CDATA[Acta Médica del Centro]]></journal-title>
<abbrev-journal-title><![CDATA[Acta méd centro]]></abbrev-journal-title>
<issn>2709-7927</issn>
<publisher>
<publisher-name><![CDATA[Hospital Provincial Clínico Quirúrgico Universitario Arnaldo Milián Castro]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2709-79272021000400511</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Índice predictivo para la estratificación del riesgo de enfermedad tromboembólica venosa en pacientes con hemopatías malignas]]></article-title>
<article-title xml:lang="en"><![CDATA[Predictive index for risk stratification of venous thromboembolic disease in patients with hematologic malignancies]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López Sacerio]]></surname>
<given-names><![CDATA[Agnerys]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rendón Peralta]]></surname>
<given-names><![CDATA[Sadys]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Barreto Fiu]]></surname>
<given-names><![CDATA[Eduardo Eligio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alvarez Basulto]]></surname>
<given-names><![CDATA[Norisbel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Acosta Alvarez]]></surname>
<given-names><![CDATA[Mailyn]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Provincial Clínico Quirúrgico Universitario &#8220;Arnaldo Milián Castro&#8221;  ]]></institution>
<addr-line><![CDATA[Santa Clara Villa Clara]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Pediátrico José Luis Miranda  ]]></institution>
<addr-line><![CDATA[Santa Clara Villa Clara]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Ciencias Médicas de Villa Clara  ]]></institution>
<addr-line><![CDATA[Santa Clara Villa Clara]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Hospital Provincial Clínico Quirúrgico Universario &#8220;Amalia Simoni&#8221;  ]]></institution>
<addr-line><![CDATA[Camagüey Camagüey]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2021</year>
</pub-date>
<volume>15</volume>
<numero>4</numero>
<fpage>511</fpage>
<lpage>520</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S2709-79272021000400511&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S2709-79272021000400511&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S2709-79272021000400511&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  la enfermedad tromboembólica venosa es una frecuente complicación en las hemopatías malignas y tiene un significativo impacto en la morbilidad y la mortalidad. A pesar de existir múltiples scores bien validados para estratificar el riesgo de esta enfermedad en tumores sólidos, las hemopatías malignas están subrepresentadas en estos modelos.  Objetivo:  diseñar un índice predictivo para la estratificación del riesgo trombótico en pacientes con hemopatías malignas.  Métodos:  se realizó un estudio observacional analítico de casos y controles en el Hospital &#8220;Arnaldo Milián Castro&#8221; de la Provincia de Villa Clara, durante el período de octubre de 2016 a enero de 2019, en 285 pacientes hospitalizados con hemopatías malignas (94 con enfermedad tromboembólica y191 sin). Para el análisis univariado fue aplicada la prueba de Chi-cuadrado, Odds Ratio para la estimación del riesgo y V de Cramer para la fuerza de asociación. La regresión logística y la curva ROC fueron aplicadas en el análisis multivariado.  Resultados:  el índice predictivo de enfermedad tromboembólica quedó compuesto por cinco factores predictores: hipercolesterolemia, actividad tumoral, inmovilidad, uso de medicamentos trombogénicos y diabetes mellitus. Se definió como alto riesgo de trombosis al paciente que obtuvo cuatro puntos o más y bajo riesgo al que tuvo menos de cuatro puntos. El índice clasificó correctamente al 81,10% de los pacientes, para una sensibilidad del 59,57% y una especificidad del 92,15%. Los valores predictivos positivos y negativos fueron de 78,87% y 82,24%, respectivamente.  Conclusiones:  el índice elaborado representó una herramienta específica y eficaz para la predicción de enfermedad tromboembólica en el paciente hospitalizado con hemopatía maligna.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  venous thromboembolic disease is a frequent complication in hematologic malignancies and has a significant impact on morbidity and mortality. Despite the existence of multiple well-validated scores to stratify the risk of this disease in solid tumors, hematological malignancies are underrepresented in these models.  Objective:  to design a predictive index for the stratification of the thrombotic risk in patients with hematologic malignancies.  Methods:  an analytical observational study of cases and controls was carried out in the &#8220;Arnaldo Milián Castro&#8221; Hospital from Villa Clara Province, during the period from October 2016 to January 2019, in 285 hospitalized patients with hematological malignancies (94 with thromboembolic disease and 191 without). For univariate analysis, Chi-square test, Odds Ratio for risk estimation and Cramer's V for strength of association were applied. Logistic regression and ROC curve were applied in the multivariate analysis.  Results:  the predictive index of thromboembolic disease was composed of five predictors: hypercholesterolemia, tumor activity, immobility, use of thrombogenic drugs and diabetes mellitus. High risk of thrombosis was defined as a patient who scored four points or more and low risk as a patient who scored less than four points. The index correctly classified 81.10% of the patients, for a sensitivity of 59.57% and a specificity of 92.15%. The positive and negative predictive values were 78.87% and 82.24%, respectively.  Conclusions:  the developed index represented a specific and effective tool for the prediction of thromboembolic disease in hospitalized patients with hematologic malignancy.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[enfermedad tromboembólica venosa]]></kwd>
<kwd lng="es"><![CDATA[hemopatías malignas]]></kwd>
<kwd lng="es"><![CDATA[índice de predicción]]></kwd>
<kwd lng="es"><![CDATA[eficacia]]></kwd>
<kwd lng="en"><![CDATA[venous thromboembolic disease]]></kwd>
<kwd lng="en"><![CDATA[hematological malignancies]]></kwd>
<kwd lng="en"><![CDATA[prediction index]]></kwd>
<kwd lng="en"><![CDATA[efficacy]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>Centros para el Control y la Prevención de Enfermedades</collab>
<source><![CDATA[Tromboembolismo venoso (coágulos de sangre). ¿En riesgo de tener coágulos de sangre?]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Atlanta ]]></publisher-loc>
<publisher-name><![CDATA[CDC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Salvador]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Segura]]></surname>
<given-names><![CDATA[Á]]></given-names>
</name>
</person-group>
<source><![CDATA[Modelos predictivos de riesgo de enfermedad tromboembólica venosa]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[SEOM]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<collab>Oficina Nacional de Estadística e Información</collab>
<source><![CDATA[Anuario Estadístico de Cuba 2018]]></source>
<year>2019</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[ONEI]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López-Sacerio]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez-Basulto]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Batista-Hernández]]></surname>
<given-names><![CDATA[NE]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez-Acosta]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores predictivos de trombosis en pacientes con hemopatías malignas]]></article-title>
<source><![CDATA[Rev Cubana Hematol Inmunol Hemoter]]></source>
<year>2017</year>
<volume>33</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<collab>Grupo de Coordinación de Expertos</collab>
<source><![CDATA[Trombosis asociada al cáncer (TAC), una causa de muerte muchas veces ignorada en pacientes con cáncer: medidas necesarias para mejorar los resultados en salud y reducir la mortalidad. (Adaptación española del White Paper original)]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Dinamarca ]]></publisher-loc>
<publisher-name><![CDATA[LEO Pharma]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heit]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Spencer]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[White]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The epidemiology of venous thromboembolism]]></article-title>
<source><![CDATA[J Thromb Thrombolysis]]></source>
<year>2016</year>
<volume>41</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-14</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khorana]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Kamphuisen]]></surname>
<given-names><![CDATA[PW]]></given-names>
</name>
<name>
<surname><![CDATA[Meyer]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Bauersachs]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Janas]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Jarner]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tissue factor as a predictor of recurrent venous thromboembolism in malignancy: Biomarker analyses of the CATCH trial]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>2017</year>
<volume>35</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1078-85</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stuck]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Spirk]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Schaudt]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kucher]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk assessment models for venous thromboembolism in acutely ill medical patients. A systematic review]]></article-title>
<source><![CDATA[Thromb Haemost]]></source>
<year>2017</year>
<volume>117</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>801-8</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Silveira]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Carlomagno]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[De Andrés]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ventura]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Baccelli]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación de la prescripción de trombo-profilaxis farmacológica y valoración del impacto que generan distintas estrategias para mejorar su indicación]]></article-title>
<source><![CDATA[Rev Urug Med Int]]></source>
<year>2017</year>
<volume>2</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>21-4</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[van Es]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Di Nisio]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cesarman]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Kleinjan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Otten]]></surname>
<given-names><![CDATA[H-M]]></given-names>
</name>
<name>
<surname><![CDATA[Mahé]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study]]></article-title>
<source><![CDATA[Haematologica]]></source>
<year>2017</year>
<volume>102</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1494-501</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van Es]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Louzada]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Carrier]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Tagalakis]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Gross]]></surname>
<given-names><![CDATA[PL]]></given-names>
</name>
<name>
<surname><![CDATA[Shivakumar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study]]></article-title>
<source><![CDATA[Thromb Res]]></source>
<year>2018</year>
<volume>163</volume>
<numero>41-46</numero>
<issue>41-46</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Crous-Bou]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Harrington]]></surname>
<given-names><![CDATA[LB]]></given-names>
</name>
<name>
<surname><![CDATA[Kabrhel]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Environmental and genetic risk factors associated with venous thromboembolism]]></article-title>
<source><![CDATA[Semin Thromb Hemost]]></source>
<year>2016</year>
<volume>42</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>808-20</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Antic]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Milic]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Nikolovski]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Todorovic]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bila]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Djurdjevic]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients]]></article-title>
<source><![CDATA[Am J Hematol]]></source>
<year>2016</year>
<volume>91</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1014-9</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garcia-Raso]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ene]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
<name>
<surname><![CDATA[Llamas Sillero]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Alterations of lipid profile are a risk factor for venous thromboembolism and thrombotic complications]]></article-title>
<source><![CDATA[Eur J Lipid Sci Technol]]></source>
<year>2014</year>
<volume>116</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>514-20</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bravo-Grau]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estudios de exactitud diagnóstica: Herramientas para su interpretación]]></article-title>
<source><![CDATA[Rev Chil Radiol]]></source>
<year>2015</year>
<volume>21</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>158-64</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moratalla Rodríguez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lectura crítica de artículos de pruebas diagnósticas II: análisis de resultados]]></article-title>
<source><![CDATA[Radiol]]></source>
<year>2015</year>
<volume>57</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>22-8</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[XL]]></given-names>
</name>
<name>
<surname><![CDATA[Pan]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validity of Padua risk assessment scale for assessing the risk of deep venous thrombosis in hospitalized patients]]></article-title>
<source><![CDATA[Zhonghua Nei Ke Za Zhi]]></source>
<year>2018</year>
<volume>57</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>514-7</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Antic]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Milic]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Nikolovski]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Todorovic]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bila]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Djurdjevic]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparative analysis of predictive models for thromboembolic events in lymphoma patients]]></article-title>
<source><![CDATA[Hematol Oncol]]></source>
<year>2017</year>
<volume>35</volume>
<numero>52</numero>
<issue>52</issue>
<page-range>416</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mulder]]></surname>
<given-names><![CDATA[FI]]></given-names>
</name>
<name>
<surname><![CDATA[Candeloro]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kamphuisen]]></surname>
<given-names><![CDATA[PW]]></given-names>
</name>
<name>
<surname><![CDATA[Di Nisio]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bossuyt]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Guman]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Haematologica]]></source>
<year>2019</year>
<volume>104</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1277-87</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
